Good morning :)
Place Order
Add to Watchlist

Rossari Biotech Ltd

ROSSARI

Rossari Biotech Ltd

ROSSARI
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹4,527 cr, stock is ranked 804
Moderate RiskStock is 2.01x as volatile as Nifty
829.901.48% (+12.10)
829.901.48% (+12.10)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹4,527 cr, stock is ranked 804
Moderate RiskStock is 2.01x as volatile as Nifty

How to use scorecard? Learn more

MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹4,527 cr, stock is ranked 804
Moderate RiskStock is 2.01x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
32.624.320.06%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
30.643.481.33%

Forecast & Ratings

Detailed Forecast 
75%
Analysts have suggested that investors can buy this stock

from 4 analysts

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Rossari Biotech is engaged in business of textile and specialty chemical manufacturing.

Investor Presentation

View older 

Oct 20, 2024

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 28.87%, vs industry avg of 6.09%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.93% to 2.19%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 23.4%, vs industry avg of -1.55%

Loading...

Financial YearFY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue517.13603.81718.471,496.511,662.321,838.181,930.75
Raw Materialssubtract355.23369.26470.621,128.081,183.961,357.041,666.39
Power & Fuel Costsubtract1.261.742.4011.9220.4023.30
Employee Costsubtract27.5237.2141.9867.9398.62103.13
Selling & Administrative Expensessubtract38.0750.7936.7037.9358.8961.54
Operating & Other expensessubtract16.5936.5734.1153.6771.0035.79
Depreciation/Amortizationsubtract12.1916.8522.8348.0662.9360.3961.69
Interest & Other Itemssubtract2.883.562.9912.6622.3219.3714.21
Taxes & Other Itemssubtract17.7122.5826.6238.6036.9646.9349.70
EPS9.4413.1615.6218.2619.4623.6825.12
DPS0.000.500.500.500.500.500.50
Payout ratio0.000.040.030.030.030.020.02

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2022

Annual report

PDF

Investor Presentation

May 24PDF
May 20PDF
FY 2023

Annual report

PDF

Investor Presentation

Apr 30PDF
Feb 5PDF
Feb 5PDF
+2 more
FY 2024

Annual report

PDF

Investor Presentation

Jul 29PDF
FY 2025

Annual Report Pending

Investor Presentation

Oct 20PDF
Oct 20PDF
 

Peers & Comparison

Comparing 3 stocks from 
MaterialsSpecialty Chemicals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Rossari Biotech Ltd34.644.320.06%
Gujarat Fluorochemicals Ltd105.217.710.07%
Vinati Organics Ltd61.398.060.37%
Akzo Nobel India Ltd43.6814.011.59%

Price Comparison

Compare ROSSARI with any stock or ETF
Compare ROSSARI with any stock or ETF
ROSSARI
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding68.27%13.18%4.15%3.74%10.65%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep6.12%5.75%4.14%4.03%3.83%3.74%

Mutual Funds Holding Trend

Mutual Fund Holding

Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

Top 5 Mutual Funds holding Rossari Biotech Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
SBI Small Cap Fund - Growth - Direct Plan

Growth
3.7201%0.49%-0.02%58/63 (-4)
UTI Flexi Cap Fund - Growth - Direct Plan

Growth
3.1806%0.56%-0.02%59/70 (0)
Canara Robeco Small Cap Fund - Growth - Direct Plan

Growth
1.9048%0.70%-0.04%92/105 (-20)

Compare 3-month MF holding change on Screener

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividend Cuts

Dividends are the portion of earnings that a company distributes to all its shareholders every year

ROSSARI has increased or maintained dividend levels over the last 5 years

Dividend Yield

Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.06%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹0.61 every year

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateAug 16, 2024

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Aug 16, 2024

Cash Dividend

Ex DateEx DateMay 24, 2023

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

May 24, 2023

Cash Dividend

Ex DateEx DateJul 7, 2022

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Jul 7, 2022

Cash Dividend

Ex DateEx DateSep 8, 2021

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Sep 8, 2021

News & Opinions
Corporate
Rossari Biotech to hold EGM

Rossari Biotech announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 11 November 2024 .Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Earnings
Rossari Biotech consolidated net profit rises 7.22% in the September 2024 quarter

Net profit of Rossari Biotech rose 7.22% to Rs 35.33 crore in the quarter ended September 2024 as against Rs 32.95 crore during the previous quarter ended September 2023. Sales rose 3.08% to Rs 498.35 crore in the quarter ended September 2024 as against Rs 483.47 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales498.35483.47 3 OPM %13.2313.15 - PBDT63.2759.92 6 PBT48.1144.81 7 NP35.3332.95 7 Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
Rossari Biotech announces board meeting date

Rossari Biotech will hold a meeting of the Board of Directors of the Company on 19 October 2024.Powered by Capital Market - Live

3 weeks agoCapital Market - Live

Glenmark Life Sciences Ltd leads gainers in ‘A’ group

3 months agoBusiness Standard

Rossari Biotech Q1 Results Review - Steady Performance: ICICI Securities

3 months agoBloomberg Quint

Add Rossari Biotech, target price Rs 885: ICICI Securities

3 months agoEconomic Times
Corporate
Rossari Biotech schedules AGM

Rossari Biotech announced that the 15th Annual General Meeting (AGM) of the company will be held on 23 August 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live

Rossari Biotech consolidated net profit rises 19.44% in the June 2024 quarter

3 months agoBusiness Standard
Stock Radar I Rossari Biotech recently experienced a robust breakout from Fibonacci golden zone
11 months agoThe Economic Times

Accumulate Rossari Biotech; target of Rs 843: KR Choksey

1 year agoMoneycontrol